Nephrology Consultation for Severe SGLT2 Inhibitor-Induced Ketoacidosis in Type 2 Diabetes: Case Report

Nephrology Consultation for Severe SGLT2 Inhibitor-Induced Ketoacidosis in Type 2 Diabetes: Case Report

Euglycemic diabetic ketoacidosis (euDKA) related to sodium-glucose cotransporter 2 inhibitor (SGLT2-I), despite being reported as consistent, though infrequent, adverse effect in all trials on SGLT2-I in type 2 diabetes mellitus (T2D), still remains poorly known in the real world. On the other hand,...

Description complète

Détails bibliographiques
Auteurs principaux: Felice Nappi, Antonietta La Verde, Giovanni Carfora, Carlo Garofalo, Michele Provenzano, Ferdinando Carlo Sasso, Luca De Nicola
Format: Article
Langue:English
Publié: MDPI AG 2019-08-01
Collection:Medicina
Sujets:
diabetic nephropathy
SGLT2 inhibition
AKI
ketoacidosis
diabetes mellitus
Accès en ligne:https://www.mdpi.com/1010-660X/55/8/462

Internet

https://www.mdpi.com/1010-660X/55/8/462

Documents similaires